表紙：点鼻スプレー市場規模、シェア、成長分析、製品タイプ別、剤形別、容器デザイン別、治療クラス別、処方/入手可能性別、用途別、地域別-2025年～2032年産業予測

市場調査レポート

商品コード

1758558

点鼻スプレー市場規模、シェア、成長分析、製品タイプ別、剤形別、容器デザイン別、治療クラス別、処方/入手可能性別、用途別、地域別-2025年～2032年産業予測

Nasal Spray Market Size, Share, and Growth Analysis, By Product Type, By Dosage Form, By Container Design, By Therapeutic Class, By Prescription/Availability, By Application, By Region - Industry Forecast 2025-2032

出版日: 2025年06月20日
発行: SkyQuest
ページ情報: 英文 193 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 766,910円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 897,140円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,027,370円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.70円

全表示
概要
目次

概要

サンプル依頼リストに入れる

点鼻スプレーの世界市場規模は2023年に263億米ドルとなり、予測期間（2025年～2032年）のCAGRは7.1%で、2024年の281億7,000万米ドルから2032年には487億6,000万米ドルに成長する見通しです。

世界の点鼻スプレー市場は、先進国市場と新興国市場の両方において、アレルギー性鼻炎や副鼻腔炎を含む呼吸器疾患や鼻疾患の有病率が上昇していることを背景に力強い成長を遂げています。より多くの患者が非侵襲的な治療オプションを求める中、革新的な鼻腔送達システムに対する製薬企業の投資が増加しています。ジェネリック鼻腔用製剤の承認が増加したことで、鼻腔用製剤へのアクセスが拡大し、購入しやすくなっています。主な動向には、新たな経鼻用途の研究開発の活発化や、製品開発の加速を目的とした戦略的パートナーシップなどがあり、SK Bioscienceがビル＆メリンダ・ゲイツ財団から220万米ドルを獲得したような多額の助成金がその例です。メーカー各社はまた、製剤の安定性を向上させるために品質設計の原則に重点を置き、患者の服薬アドヒアランスを向上させ、経鼻スマートデバイスの使用状況を監視するためにデジタルヘルス技術を統合しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022年～2024年）

主要企業プロファイル

EMERGENT（U.S.）
Cipla Inc.（India）
Sandoz International GmbH（A Part of Novartis）（Switzerland）
Aytu Health（A subsidiary of Aytu BioPharma, Inc.）（U.S.）
Bayer AG（Germany）
GlaxoSmithKline plc.（U.K.）
Assertio Therapeutics, Inc.（U.S.）
Aurena Laboratories（Sweden）
J Pharmaceuticals（U.S.）
St. Renatus（U.S.）
Ultratech India Limited（India）
Teva Pharmaceuticals USA, Inc.（U.S.）
Pfizer Inc.（U.S.）
LEEFORD HEALTHCARE LTD（India）
Aishwarya Group（India）

結論と提言

Product Code: SQMIG35B2234

Global Nasal Spray Market size was valued at USD 26.3 billion in 2023 and is poised to grow from USD 28.17 billion in 2024 to USD 48.76 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global nasal spray market is experiencing robust growth driven by the rising prevalence of respiratory and nasal disorders, including allergic rhinitis and sinusitis, in both developed and emerging markets. As more patients seek non-invasive treatment options, there's an uptick in pharmaceutical investments in innovative nasal delivery systems. The increase in approvals for generic nasal formulations is broadening access and enhancing affordability. Key trends include heightened R&D for new intranasal applications and strategic partnerships aimed at accelerating product development, exemplified by significant grants like SK Bioscience's USD 2.2 million from the Bill & Melinda Gates Foundation. Manufacturers are also focusing on quality by design principles for better formulation stability and are integrating digital health technologies to improve patient adherence and monitor usage of nasal smart devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nasal Spray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nasal Spray Market Segments Analysis

Global Nasal Spray Market is segmented by Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User and region. Based on Product Type, the market is segmented into Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray and Others. Based on Dosage Form, the market is segmented into Multi Dose, Unit/Single Dose and Bi Dose. Based on Container Design, the market is segmented into Pump Bottles and Pressurized Canisters. Based on Therapeutic Class, the market is segmented into Antihistamine, Nasal Steroids, Mast Cell Inhibitor and Anticholinergic. Based on Prescription/Availability, the market is segmented into Over the Counter and Prescribed. Based on Application, the market is segmented into Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination and Others. Based on End-User, the market is segmented into Home Care Settings, Hospitals, Clinics and Community Health Care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nasal Spray Market

The escalating prevalence of allergic rhinitis, chronic sinusitis, and various respiratory ailments significantly drives the demand for nasal sprays in the global market. Factors such as urbanization and rising air pollution levels contribute to higher allergen sensitivity among the population. Additionally, aging demographics face reduced mucociliary function, making them more prone to nasal congestion and inflammation. As individuals increasingly look for swift symptom relief with limited systemic side effects, healthcare providers and insurance companies are advocating for targeted intranasal treatments. This trend is further fueling an increase in both prescription and over-the-counter sales across the globe.

Restraints in the Global Nasal Spray Market

The Global Nasal Spray market faces significant challenges due to its unique classification as both a drug and a medical device, which results in intricate regulatory processes that differ across regions. For generic nasal spray formulations, proving bioequivalence necessitates comprehensive clinical and in vitro testing, leading to extended timelines for market entry and heightened development expenses. Additionally, innovative biologic or vaccine candidates that are administered intranasally encounter even stricter safety and immunogenicity standards. These regulatory obstacles can discourage smaller companies from entering the market, hinder timely product launches, and impede the overall rate of innovation within the nasal spray sector.

Market Trends of the Global Nasal Spray Market

The Global Nasal Spray market is witnessing a transformative trend driven by the integration of advanced device technology and digital health solutions. Cutting-edge nasal spray devices now feature breath-activation mechanisms, dose counters, and Bluetooth-enabled sensors, evolving from their traditionally low-tech origins into sophisticated therapeutic tools. Collaborations with digital health firms enable the development of companion applications that track usage patterns, remind patients to adhere to their regimens, and share vital adherence data with healthcare providers. This convergence of precision engineering and real-time analytics not only enhances dosage accuracy and patient compliance but also facilitates value-based care models and remote monitoring, particularly in managing allergies and chronic sinusitis conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer Buying Behavior Analysis

Global Nasal Spray Market Size by Product Type & CAGR (2025-2032)

Market Overview
Decongestion Nasal Spray
Steroid Nasal Spray
Salt Water Solution/ Saline Nasal Spray
Others

Global Nasal Spray Market Size by Dosage Form & CAGR (2025-2032)

Market Overview
Multi Dose
Unit/Single Dose
Bi Dose

Global Nasal Spray Market Size by Container Design & CAGR (2025-2032)

Market Overview
Pump Bottles
Pressurized Canisters

Global Nasal Spray Market Size by Therapeutic Class & CAGR (2025-2032)

Market Overview
Antihistamine
Nasal Steroids
Mast Cell Inhibitor
Anticholinergic

Global Nasal Spray Market Size by Prescription/Availability & CAGR (2025-2032)

Market Overview
Over the Counter
Prescribed

Global Nasal Spray Market Size by Application & CAGR (2025-2032)

Market Overview
Nasal Congestion
Allergic and Non-Allergic Rhinitis
Central Nervous System Disorders
Vaccination
Others

Global Nasal Spray Market Size by End-User & CAGR (2025-2032)

Market Overview
Home Care Settings
Hospitals
Clinics
Community Health Care

Global Nasal Spray Market Size & CAGR (2025-2032)

North America (Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User)
- US
- Canada
Europe (Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Dosage Form, Container Design, Therapeutic Class, Prescription/Availability, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

EMERGENT (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Inc. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz International GmbH (A Part of Novartis) (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aytu Health (A subsidiary of Aytu BioPharma, Inc.) (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc. (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Assertio Therapeutics, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurena Laboratories (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J Pharmaceuticals (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Renatus (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ultratech India Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals USA, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LEEFORD HEALTHCARE LTD (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aishwarya Group (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

点鼻スプレー市場規模、シェア、成長分析、製品タイプ別、剤形別、容器デザイン別、治療クラス別、処方/入手可能性別、用途別、地域別-2025年～2032年産業予測

Nasal Spray Market Size, Share, and Growth Analysis, By Product Type, By Dosage Form, By Container Design, By Therapeutic Class, By Prescription/Availability, By Application, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

点鼻スプレー市場規模：製品タイプ別& CAGR（2025年～2032年）

点鼻スプレー市場規模：剤形別& CAGR（2025年～2032年）

点鼻スプレー市場規模：容器デザイン別& CAGR（2025年～2032年）

点鼻スプレー市場規模：治療クラス別& CAGR（2025年～2032年）

点鼻スプレー市場規模：処方/入手可能性別& CAGR（2025年～2032年）

点鼻スプレー市場規模：用途別& CAGR（2025年～2032年）

点鼻スプレー市場規模：エンドユーザー別& CAGR（2025年～2032年）

点鼻スプレー市場規模& CAGR（2025年～2032年）